A carregar...
GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
BACKGROUND: First Spanish trial of Ewing sarcoma (ES) including adults and children with the aim to test the efficacy of Gemcitabine and Docetaxel (G/D) in newly diagnosed high-risk (HR) patients. METHODS: This was a prospective, multicentric, non-randomised, open study for patients ⩽40 years with n...
Na minha lista:
Publicado no: | Br J Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5589997/ https://ncbi.nlm.nih.gov/pubmed/28787430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.252 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|